A prospective clinical trial to establish the significance of interim FDG and FLT PET/CT scans as biomarkers of patient prognosis and individualised radiation therapy in non-small cell lung cancer

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1003895

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Positron Emission Tomography (PET)/Computed Tomography (CT) scanners pinpoint the location of cancer cells in people prior to and after treatment. This innovative study will use during treatment PET/CT scans to establish the response of lung tumours to radiation therapy (RT). We will use these scans to simulate the delivery of highly targeted, individualised RT and to predict patient prognosis, with the ultimate aim of increasing survival and minimising side effects in patients with lung cancer

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2016

Funding Scheme: Project Grants

Funding Amount: $532,902.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Radiation Therapy

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cancer prognosis | individualising management | lung cancer | positron emission tomography (PET) | prognostic markers | radiation biology | radiation therapy

Related Links